ELOVL5 Antibody
Cat# MBS8582633-0,1mL-Biotin
Size : 0.1mL(Biotin)
Brand : MyBiosource
ELOVL5 Antibody – Rabbit Polyclonal
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS8582633MBS8582633 is an antibody targeting ELOVL5. Also known as ELOVL5 Antibody. Reactive in Human, Monkey. Host: Rabbit. Rabbit polyclonal antibody to ELOVL5 More details
Product Overview
Online Datasheet in PDFProduct Name
ELOVL5, Polyclonal Antibody
Full Product Name
ELOVL5 Antibody
Product Gene Name
anti-ELOVL5 antibody
Product Synonym Names
ELOVL2; Elongation of very long chain fatty acids protein 5; 3-keto acyl-CoA synthase ELOVL5; ELOVL fatty acid elongase 5; ELOVL FA elongase 5; Fatty acid elongase 1; hELO1; Very-long-chain 3-oxoacyl-CoA synthase 5
Clonality
Polyclonal
Isotype
IgG
Host
Rabbit
Species Reactivity
Human, Monkey
Form/Format
Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH7.3, 30% glycerol, and 0.01% sodium azide.
Purity/Purification
The antibody was purified by immunogen affinity chromatography.
Specificity
Recognizes endogenous levels of ELOVL5 protein.
Preparation and Storage
Shipped at 4 degree C. Upon delivery aliquot and store at -20 degree C for one year. Avoid freeze/thaw cycles.
Molecular Weight
35,293 Da
Chromosome Location
Chromosome: 6; NC_000006.11 (53132196..53213977, complement). Location: 6p21.1-p12.1
OMIM
611805
Immunogen
KLH-conjugated synthetic peptide encompassing a sequence within the C-term region of human ELOVL5. The exact sequence is proprietary.
Product Categories/Family for anti-ELOVL5 antibody
Primary Antibody
ISO Certification
Manufactured in an ISO 9001:2015 Certified Laboratory.
Applications Tested/Suitable for anti-ELOVL5 antibody
Western Blot (WB), Immunohistochemistry (IHC)
Application Notes for anti-ELOVL5 antibody
WB: 1:500-1:1000
IHC: 1:50-1:200
IHC: 1:50-1:200
Other Notes
Small volumes of anti-ELOVL5 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for ELOVL5. It may not necessarily be applicable to this product.
NCBI Official Full Name
elongation of very long chain fatty acids protein 5 isoform 2
NCBI Official Synonym Full Names
ELOVL fatty acid elongase 5
NCBI Official Symbol
ELOVL5
NCBI Official Synonym Symbols
HELO1; dJ483K16.1; RP3-483K16.1
UniProt Protein Name
Elongation of very long chain fatty acids protein 5
UniProt Synonym Protein Names
3-keto acyl-CoA synthase ELOVL5; ELOVL fatty acid elongase 5; ELOVL FA elongase 5; Fatty acid elongase 1; hELO1; Very-long-chain 3-oxoacyl-CoA synthase 5
UniProt Gene Name
ELOVL5
UniProt Synonym Gene Names
ELOVL2; ELOVL FA elongase 5; hELO1
UniProt Entry Name
ELOV5_HUMAN
NCBI Protein Information
elongation of very long chain fatty acids protein 5; ELOVL FA elongase 5; fatty acid elongase 1; 3-keto acyl-CoA synthase ELOVL5; very-long-chain 3-oxoacyl-CoA synthase 5; homolog of yeast long chain polyunsaturated fatty acid elongatio; homolog of yeast
NCBI Summary for ELOVL5
ELOVL5 plays a role in elongation of long-chain polyunsaturated fatty acids (Leonard et al., 2000 [PubMed 10970790]).[supplied by OMIM, Mar 2008]
UniProt Comments for ELOVL5
ELOVL5: Condensing enzyme that catalyzes the synthesis of monounsaturated and of polyunsaturated very long chain fatty acids Acts specifically toward polyunsaturated acyl-CoA with the higher activity toward C18:3(n-6) acyl-CoA. Belongs to the ELO family.
Protein type: Lipid Metabolism - unsaturated fatty acid biosynthesis; EC 2.3.1.199; Membrane protein, multi-pass; Membrane protein, integral
Chromosomal Location of Human Ortholog: 6p12.1
Cellular Component: endoplasmic reticulum membrane; membrane; cell soma; endoplasmic reticulum; dendrite; integral to membrane
Molecular Function: protein binding; fatty acid elongase activity
Biological Process: unsaturated fatty acid metabolic process; very-long-chain fatty acid biosynthetic process; linoleic acid metabolic process; unsaturated fatty acid biosynthetic process; triacylglycerol biosynthetic process; cellular lipid metabolic process
Disease: Spinocerebellar Ataxia 38
Show more Protein type: Lipid Metabolism - unsaturated fatty acid biosynthesis; EC 2.3.1.199; Membrane protein, multi-pass; Membrane protein, integral
Chromosomal Location of Human Ortholog: 6p12.1
Cellular Component: endoplasmic reticulum membrane; membrane; cell soma; endoplasmic reticulum; dendrite; integral to membrane
Molecular Function: protein binding; fatty acid elongase activity
Biological Process: unsaturated fatty acid metabolic process; very-long-chain fatty acid biosynthetic process; linoleic acid metabolic process; unsaturated fatty acid biosynthetic process; triacylglycerol biosynthetic process; cellular lipid metabolic process
Disease: Spinocerebellar Ataxia 38
Research Articles on ELOVL5
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Pathways associated with anti-ELOVL5 antibody
| Products by Pathway | Pathway Diagram |
|---|---|
| Biosynthesis Of Unsaturated Fatty Acids Pathway antibodies | Biosynthesis Of Unsaturated Fatty Acids Pathway Diagram |
| Biosynthesis Of Unsaturated Fatty Acids Pathway antibodies | Biosynthesis Of Unsaturated Fatty Acids Pathway Diagram |
| Fatty Acyl-CoA Biosynthesis Pathway antibodies | Fatty Acyl-CoA Biosynthesis Pathway Diagram |
| Fatty Acid Biosynthesis, Elongation, Endoplasmic Reticulum Pathway antibodies | Fatty Acid Biosynthesis, Elongation, Endoplasmic Reticulum Pathway Diagram |
| Fatty Acid Biosynthesis, Elongation, Endoplasmic Reticulum Pathway antibodies | Fatty Acid Biosynthesis, Elongation, Endoplasmic Reticulum Pathway Diagram |
| Fatty Acid Elongation Pathway antibodies | Fatty Acid Elongation Pathway Diagram |
| Fatty Acid Elongation Pathway antibodies | Fatty Acid Elongation Pathway Diagram |
| Fatty Acid, Triacylglycerol, And Ketone Body Metabolism Pathway antibodies | Fatty Acid, Triacylglycerol, And Ketone Body Metabolism Pathway Diagram |
| Linoleic Acid (LA) Metabolism Pathway antibodies | Linoleic Acid (LA) Metabolism Pathway Diagram |
| Metabolism Pathway antibodies | Metabolism Pathway Diagram |
Diseases associated with anti-ELOVL5 antibody
| Disease Name | Pubmed Publications |
|---|---|
| Fatty Liver Antibodies | >23 publications with ELOVL5 and Fatty Liver |
| Liver Diseases Antibodies | >5 publications with ELOVL5 and Liver Diseases |
| Neoplasms Antibodies | >3 publications with ELOVL5 and Neoplasms |
| Prostatic Neoplasms Antibodies | >2 publications with ELOVL5 and Prostatic Neoplasms |
| Inflammation Antibodies | >2 publications with ELOVL5 and Inflammation |
| Prostatic Diseases Antibodies | >2 publications with ELOVL5 and Prostatic Diseases |
| Hepatomegaly Antibodies | >1 publications with ELOVL5 and Hepatomegaly |
| Heart Diseases Antibodies | >1 publications with ELOVL5 and Heart Diseases |
| Liver Neoplasms Antibodies | >1 publications with ELOVL5 and Liver Neoplasms |
| Cardiovascular Diseases Antibodies | >1 publications with ELOVL5 and Cardiovascular Diseases |


